Institutional Ownership Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP). We have compiled data on the 494 institutions that hold shares in the stock, with a total of 64.3 Million shares, which have been reported (via 13F filing form) to have a value of $3.2 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Global Financial Private Client, LLC
Sarasota, FL |
Jan 13, 2025 Q4 2024 |
23
shares
|
$1,143
0.0% of portfolio
|
Q4 2023
New holding
|
|
Vital Stone Financial, LLC
Shavano Park, TX |
Oct 11, 2024 Q3 2024 |
22
shares
|
$1,093
0.0% of portfolio
|
Q2 2024
Reduced 31.25%
|
|
Institutional & Family Asset Management, LLC
|
Jul 05, 2024 Q2 2024 |
21
shares
|
$1,044
0.0% of portfolio
|
Q1 2022
Reduced 52.27%
|
|
Archer Investment Corp
|
Jan 28, 2025 Q4 2024 |
20
shares
|
$994
0.0% of portfolio
|
Q3 2024
Reduced 90.91%
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
20
shares
|
$994
0.0% of portfolio
|
Q4 2021
Reduced 97.83%
|
|
Corbenic Partners LLC
|
Jul 25, 2022 Q2 2022 |
20
shares
|
$994
0.0% of portfolio
|
Q2 2022
Reduced 66.67%
|
|
Cordasco Financial Network
|
Jul 15, 2022 Q2 2022 |
20
shares
|
$994
0.0% of portfolio
|
Q2 2022
New holding
|
|
C M Bidwell & Associates LTD
Honolulu, HI |
Feb 12, 2025 Q4 2024 |
18
shares
|
$894
0.0% of portfolio
|
Q4 2024
Reduced 67.86%
|
|
Huntington National Bank
Columbus, OH |
Feb 12, 2025 Q4 2024 |
17
shares
|
$845
0.0% of portfolio
|
Q4 2024
Reduced 94.41%
|
|
Gen Wealth Partners Inc
Zeeland, MI |
Feb 14, 2025 Q4 2024 |
16
shares
|
$795
0.0% of portfolio
|
Q1 2024
New holding
|
|
Hexagon Capital Partners LLC
|
Feb 07, 2025 Q4 2024 |
16
shares
|
$795
0.0% of portfolio
|
Q4 2024
Added 700.0%
|
|
Assetmark, Inc
|
Feb 06, 2025 Q4 2024 |
15
shares
|
$745
0.0% of portfolio
|
Q4 2024
New holding
|
|
Fieldpoint Private Securities, LLC
|
Aug 05, 2022 Q2 2022 |
15
shares
|
$745
0.0% of portfolio
|
Q3 2021
Reduced 59.46%
|
|
Org Partners LLC
Roanoke, IN |
Jan 10, 2025 Q4 2024 |
15
shares
|
$745
0.0% of portfolio
|
Q2 2024
New holding
|
|
Cape Investment Advisory, Inc.
Mcdonough, GA |
Feb 05, 2025 Q4 2024 |
15
shares
|
$745
0.0% of portfolio
|
Q2 2024
New holding
|
|
Kayne Anderson Rudnick Investment Management LLC
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
14
shares
|
$696
0.0% of portfolio
|
Q1 2024
New holding
|
|
North Star Investment Management Corp.
Chicago, IL |
Feb 10, 2025 Q4 2024 |
13
shares
|
$646
0.0% of portfolio
|
Q4 2021
Reduced 97.88%
|
|
Tucker Asset Management LLC
Littleton, CO |
Feb 12, 2025 Q4 2024 |
12
shares
|
$596
0.0% of portfolio
|
Q4 2024
New holding
|
|
Duncker Streett & CO Inc
|
Feb 05, 2025 Q4 2024 |
11
shares
|
$546
0.0% of portfolio
|
Q3 2021
New holding
|
|
Dt Investment Partners, LLC
|
Jan 30, 2025 Q4 2024 |
11
shares
|
$546
0.0% of portfolio
|
Q3 2024
New holding
|
|
New Wave Wealth Advisors LLC
Springdale, AR |
Jan 23, 2025 Q4 2024 |
10
shares
|
$497
0.0% of portfolio
|
Q4 2024
New holding
|
|
Trustcore Financial Services, LLC
|
Feb 13, 2023 Q4 2022 |
10
shares
|
$497
0.0% of portfolio
|
Q4 2021
Reduced 96.77%
|
|
Foster Dykema Cabot & CO Inc
|
Nov 14, 2023 Q3 2023 |
10
shares
|
$497
0.0% of portfolio
|
Q1 2023
New holding
|
|
Foster Dykema Cabot & Partners, LLC
Waltham, MA |
Feb 13, 2025 Q4 2024 |
10
shares
|
$497
0.0% of portfolio
|
Q4 2023
New holding
|
|
High Mark Wealth Management LLC
|
Jan 31, 2025 Q4 2024 |
10
shares
|
$497
0.0% of portfolio
|
Q2 2024
Reduced 96.92%
|